Stock listing
TSHA Stock Price, News, Filings & Events — Taysha Gene Therapies, Inc.
Selected listing: TSHA · BOATS · USD · US
This page tracks Taysha Gene Therapies, Inc.'s TSHA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TSHA:BOATS. TSHA:BOATS is the stock-level entry point for investors researching Taysha Gene Therapies, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Taysha Gene Therapies, Inc. (TSHA) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
- Ticker
- TSHA:BOATS
- Asset type
- Stock
- Market cap
- $1.64B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Taysha Gene Therapies, Inc. TSHA:BOATS stock context
This page tracks Taysha Gene Therapies, Inc.'s TSHA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TSHA:BOATS. TSHA:BOATS is the stock-level entry point for investors researching Taysha Gene Therapies, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Taysha Gene Therapies, Inc. (TSHA) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Taysha Gene Therapies, Inc.
Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 11, 2026
Taysha Gene Therapies to Release Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 11
August 4, 2026
Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Thera...
August 3, 2026
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientif...
June 25, 2026
Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of REVEAL ...
June 22, 2026
Taysha Gene Therapies, Inc. earnings calls
Taysha Gene Therapies, Inc. (TSHA) Q2 2026 Earnings Call
August 11, 2026 · Replay with transcript and chapters
Taysha Gene Therapies, Inc. (TSHA) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Taysha Gene Therapies, Inc. (TSHA) Q4 2025 Earnings Call
March 19, 2026 · Replay with transcript and chapters
Taysha Gene Therapies, Inc. (TSHA) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Taysha Gene Therapies, Inc. (TSHA) Q2 2025 Earnings Call
August 12, 2025 · Replay with transcript and chapters
Taysha Gene Therapies, Inc. (TSHA) Q1 2025 Earnings Call
May 15, 2025 · Replay with transcript and chapters
Research Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. investor report
Review AI stock analysis and investor report context for TSHA:BOATS.
Taysha Gene Therapies, Inc. company profile
View the public company page for Taysha Gene Therapies, Inc. on 6ix.
Taysha Gene Therapies, Inc. news
Read company news and market updates connected to Taysha Gene Therapies, Inc..
Taysha Gene Therapies, Inc. investor events
Find investor webinars, events, and replay context for Taysha Gene Therapies, Inc..